Dysfunction in protein clearance by the proteasome: Impact on autoinflammatory diseases

Seminars in Immunopathology

Volumn 37, Issue 4, 2015, Pages 323-333

  Brehm, Anja ^a   Krüger, Elke ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoinflammation; PRAAS; Proteasome; Proteostasis

Indexed keywords

BARICITINIB; INTERFERON; JANUS KINASE INHIBITOR; PROTEASOME; TOFACITINIB; UBIQUITIN;

AUTOINFLAMMATORY DISEASE; CELL DEATH; DIABETIC NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME REGULATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOLECULAR DIAGNOSTICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEASOME ASSOCIATED AUTOINFLAMMATORY SYNDROME; PROTEIN DEGRADATION; PROTEIN HOMEOSTASIS; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; AUTOIMMUNE DISEASES; HEREDITARY AUTOINFLAMMATORY DISEASES; METABOLISM; SYNDROME;

ANIMALS; AUTOIMMUNE DISEASES; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; INFLAMMATION; PROTEASOME ENDOPEPTIDASE COMPLEX; SYNDROME; UBIQUITIN;

EID: 84943351971     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-015-0486-4     Document Type: Review

References (69)

1. Liu Y, Jesus AA, Marrero B et al (2014) Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371:507–18. doi:10.1056/NEJMoa1312625
2. Sanchez GAM, de Jesus AA, Goldbach-Mansky R (2013) Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am 39:701–34. doi:10.1016/j.rdc.2013.08.001
3. Yamanaka K, Sasagawa Y, Ogura T (2012) Recent advances in p97/VCP/Cdc48 cellular functions. Biochim BiophysActa 1823:130–7. doi:10.1016/j.bbamcr.2011.07.001
4. Askanas V, Engel WK (2006) Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 66: S39–48. doi:10.1212/01.wnl.0000192128.13875.1e
5. Liu Y, Ramot Y, Torrelo A et al (2012) Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 64:895–907. doi:10.1002/art.33368
6. LaFerla FM (2010) Pathways linking Abeta and tau pathologies. Biochem Soc Trans 38:993–5. doi:10.1042/BST0380993
7. Sulistio YA, Heese K (2015) The ubiquitin-proteasome system and molecular chaperone deregulation in Alzheimer’s disease. Mol Neurobiol. doi:10.1007/s12035-014-9063-4
8. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509. doi:10.1038/nrn2168
9. Joshi-Barr S, Bett C, Chiang W-C et al (2014) De novo prion aggregates trigger autophagy in skeletal muscle. J Virol 88:2071–82. doi:10.1128/JVI.02279-13
10. Deriziotis P, André R, Smith DM et al (2011) Misfolded PrP impairs the UPS by interactionwith the 20S proteasome and inhibition of substrate entry. EMBO J 30:3065–77. doi:10.1038/emboj.2011.224
11. Ebstein F, Kloetzel P-M, Krüger E, Seifert U (2012) Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell Mol Life Sci 69:2543–58. doi:10.1007/s00018-012-0938-0
12. Krüger E, Kloetzel P-M (2012) Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. Curr Opin Immunol 24:77–83. doi:10.1016/j.coi.2012.01.005
13. Ciechanover A (2013) Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Bioorg Med Chem 21:3400–10. doi:10.1016/j.bmc.2013.01.056
14. Groll M, Ditzel L, Löwe J et al (1997) Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386:463–71. doi:10.1038/386463a0
15. Vigneron N, Van den Eynde BJ (2014) Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex. Biomolecules 4:994–1025. doi:10.3390/biom4040994
16. Gu ZC, Enenkel C (2014) Proteasome assembly. Cell Mol Life Sci 71:4729–45. doi:10.1007/s00018-014-1699-8
17. Sahara K, Kogleck L, Yashiroda H, Murata S (2014) The mechanism for molecular assembly of the proteasome. Adv Biol Regul 54:51–8. doi:10.1016/j.jbior.2013.09.010
18. Kniepert A, Groettrup M (2014) The unique functions of tissuespecific proteasomes. Trends Biochem Sci 39:17–24. doi:10.1016/j.tibs.2013.10.004
19. Fabre B, Lambour T, Garrigues L et al (2015) Deciphering preferential interactions within supramolecular protein complexes: the proteasome case. Mol Syst Biol 11:771, doi: 10.15252/msb.20145497
20. Kriegenburg F, Poulsen EG, Koch A et al (2011) Redox control of the ubiquitin-proteasome system: from molecular mechanisms to functional significance. Antioxid Redox Signal 15:2265–99. doi: 10.1089/ars.2010.3590
21. Seifert U, Bialy LP, Ebstein F et al (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142:613–24. doi:10.1016/j.cell.2010.07.036
22. Ebstein F, Voigt A, Lange N et al (2013) Immunoproteasomes are important for proteostasis in immune responses. Cell 152:935–7. doi:10.1016/j.cell.2013.02.018
23. Pickering AM, Koop AL, Teoh CY et al (2010) The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 432:585–94. doi:10.1042/BJ20100878
24. Fehling H, Swat W, Laplace C et al (1994) MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265(80): 1234–1237. doi:10.1126/science.8066463
25. Opitz E, Koch A, Klingel K et al (2011) Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathog 7:e1002233. doi:10.1371/journal.ppat.1002233
26. Strehl B, Joeris T, Rieger M et al (2006) Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cells. J Immunol 177:6238–6244. doi:10.4049/jimmunol.177.9.6238
27. Ishii K, Hisaeda H, Duan X et al (2006) The involvement of immunoproteasomes in induction of MHC class I-restricted immunity targeting Toxoplasma SAG1. Microbes Infect 8:1045–53. doi: 10.1016/j.micinf.2005.10.023
28. Hussong SA, Kapphahn RJ, Phillips SL et al (2010) Immunoproteasome deficiency alters retinal proteasome’s response to stress. J Neurochem 113:1481–90. doi:10.1111/j.1471-4159.2010.06688.x
29. Chou B, Hisaeda H, Shen J et al (2008) Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein. Microbes Infect 10:241–50. doi:10.1016/j.micinf.2007.11.010
30. Zaiss DMW, Bekker CPJ, Gröne A et al (2011) Proteasome immunosubunits protect against the development of CD8 T cellmediated autoimmune diseases. J Immunol 187:2302–9. doi:10.4049/jimmunol.1101003
31. Eleftheriadis T, Pissas G, Antoniadi G et al (2013) CD8+ T-cell auto-reactivity is dependent on the expression of the immunoproteasome subunit LMP7 in exposed to lipopolysaccharide antigen presenting cells and epithelial target cells. Autoimmunity 46:439–45. doi:10.3109/08916934.2013.801460
32. Krause S, Kuckelkorn U, Dörner T et al (2006) Immunoproteasome subunit LMP2 expression is deregulated in Sjogren’s syndrome but not in other autoimmune disorders. Ann Rheum Dis 65:1021–7. doi:10.1136/ard.2005.045930
33. Hayashi T, Faustman D (2000) Defective function of the proteasome in autoimmunity: involvement of impaired NF-kappaB activation. Diabetes Technol Ther 2:415–28
34. Arima K, Kinoshita A, Mishima H et al (2011) Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci U S A 108:14914–9. doi:10.1073/pnas.1106015108
35. Agarwal AK, Xing C, DeMartino GN et al (2010) PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 87:866–72. doi:10.1016/j.ajhg.2010.10.031
36. Kitamura A, Maekawa Y, Uehara H et al (2011) A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 121:4150–60. doi:10.1172/JCI58414DS1
37. McDermott A, Jesus AA, Liu Yet al (2013) A case of proteasomeassociated auto-inflammatory syndrome with compound heterozygous mutations. J Am Acad Dermatol 69:e29–e32
38. Mégarbané A, Sanders A, Chouery E et al (2002) An unknown autoinflammatory syndrome associated with short stature and dysmorphic features in a young boy. J Rheumatol 29:1084–7
39. Torrelo A, Patel S, Colmenero I et al (2010) Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol 62:489–95. doi:10.1016/j.jaad.2009.04.046
40. McDermott A, Jacks J, Kessler M et al (2014) Proteasomeassociated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management. Int J Dermatol. doi:10.1111/ijd.12695
41. Kluk J, Rustin M, Brogan PA et al (2013) CANDLE syndrome: a report of a novel mutation and review of the literature. Br J Dermatol. doi:10.1111/bjd.12600
42. Oyanagi K, Sasaki K, Ohama E et al (1987) An autopsy case of a syndrome with muscular atrophy, decreased subcutaneous fat, skin eruption and hyper gamma-globulinemia: peculiar vascular changes and muscle fiber degeneration. Acta Neuropathol 73:313–9
43. Qureshi N, Perera P-Y, Shen J et al (2003) The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J Immunol 171:1515–1525. doi:10.4049/jimmunol.171.3.1515
44. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11: 373–84. doi:10.1038/ni.1863
45. Katsuyama M (2010) NOX/NADPH oxidase, the superoxidegenerating enzyme: its transcriptional regulation and physiological roles. J Pharmacol Sci 114:134–46
46. Yewdell JW (2011) DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 32: 548–58. doi:10.1016/j.it.2011.08.001
47. Warnatsch A, Bergann T, Krüger E (2013) Oxidation matters: the ubiquitin proteasome system connects innate immune mechanisms with MHC class I antigen presentation. Mol Immunol 55:106–9. doi:10.1016/j.molimm.2012.10.007
48. Szeto J, Kaniuk NA, Canadien V et al (2014) ALIS are stressinduced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2:189–199. doi:10.4161/auto.2731
49. Senft D, Ronai ZA (2015) UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci. doi:10.1016/j.tibs.2015.01.002
50. Urano F, Wang X, Bertolotti A et al (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287:664–6
51. Menu P, Mayor A, Zhou R et al (2012) ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis 3:e261. doi:10.1038/cddis.2011.132
52. Lerner AG, Upton J-P, Praveen PVK et al (2012) IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 16:250–64. doi:10.1016/j.cmet.2012.07.007
53. Kanazawa N (2012) Nakajo-Nishimura syndrome: an autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy. Allergol Int 61:197–206. doi:10.2332/allergolint.11-RAI-0416
54. Zhang X, Bogunovic D, Payelle-Brogard B et al (2014) Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature 517:89–93. doi:10.1038/nature13801
55. Baechler EC, Batliwalla FM, Karypis G et al (2003) Interferoninducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100:2610–5. doi:10.1073/pnas.0337679100
56. Crow YJ (2013) Aicardi-Goutières syndrome. Handb Clin Neurol 113:1629–35. doi:10.1016/B978-0-444-59565-2.00031-9
57. Briggs TA, Rice GI, Daly S et al (2011) Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 43:127–31. doi:10.1038/ng.748
58. Qian M-X, Pang Y, Liu CH et al (2013) Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis. Cell 153:1012–24. doi:10.1016/j.cell.2013.04.032
59. Stadtmueller BM, Kish-Trier E, Ferrell K et al (2012) Structure of a proteasome Pba1-Pba2 complex: implications for proteasome assembly, activation, and biological function. J Biol Chem 287: 37371–82. doi:10.1074/jbc.M112.367003
60. Fricke B, Heink S, Steffen J et al (2007) The proteasomematuration protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum. EMBO Rep 8:1170–5. doi:10.1038/sj.embor.7401091
61. Hirano Y, Hendil KB, Yashiroda H et al (2005) A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes. Nature 437:1381–5. doi:10.1038/nature04106
62. Paraskevopoulos K, Kriegenburg F, Tatham MH et al (2014) Dss1 is a 26S proteasome ubiquitin receptor. Mol Cell 56:453–61. doi: 10.1016/j.molcel.2014.09.008
63. Kim Y-C, DeMartino GN (2011) C termini of proteasomal ATPases play nonequivalent roles in cellular assembly of mammalian 26S proteasome. J Biol Chem 286:26652–66. doi:10.1074/jbc.M111.246793
64. Cascio P (2014) PA28αβ: the enigmatic magic ring of the proteasome? Biomolecules 4:566–84. doi:10.3390/biom4020566
65. De Graaf N, van Helden MJG, Textoris-Taube K et al (2011) PA28 and the proteasome immunosubunits play a central and independent role in the production ofMHC class I-binding peptides in vivo. Eur J Immunol 41:926–35. doi:10.1002/eji.201041040
66. Mao I, Liu J, Li X, Luo H (2008) REGgamma, a proteasome activator and beyond? Cell Mol Life Sci 65:3971–80. doi:10.1007/s00018-008-8291-z
67. Lehmann A, Niewienda A, Jechow K et al (2010) Ecm29 fulfils quality control functions in proteasome assembly. Mol Cell 38: 879–88. doi:10.1016/j.molcel.2010.06.016
68. Gorbea C, Goellner GM, Teter K et al (2004) Characterization of mammalian Ecm29, a 26S proteasome-associated protein that localizes to the nucleus and membrane vesicles. J Biol Chem 279: 54849–61. doi:10.1074/jbc.M410444200
69. Tomko RJ Jr, Hochstrasser M (2013) Molecular architecture and assembly of the eukaryotic proteasome. Annu Rev Biochem. doi: 10.1146/annurev-biochem-060410-150257